血液系统恶性肿瘤中靶向 ROR1 的治疗进展
Therapeutic advances in the targeting of ROR1 in hematological cancers.
65.1分
★★★☆☆
站内排序·非疗效
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Therapeutic advances in the targeting of ROR1 in hematological cancers.
CAR-T therapy in non-small cell lung cancer: Clinical prospects, potential, and strategies for cardiotoxicity management.
Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors.
Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.
MEMBER ACCOUNT
登录成功会直接打开下一页。